International scientific guideline: Reflection paper on assessment of cardiovascular safety profile of medicinal products

About this guideline

Categories:  Clinical efficacy and safety | Cardiovascular system | Hypertension

Access this international scientific guideline

TGA annotations

Published for information January 2017

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.